Skip Navigation

The 2026 Diversion Trends Report

0

66% of hospitals report having full-time staff dedicated to diversion monitoring, most commonly one or two individuals.

0

6% of all controlled substance transactions contained documentation variances that required further review.

0

83% of diversion-focused staff say their organization has a cross-functional diversion committee in place.

83% of diversion investigations are triggered by software alerts

With 94% of surveillance teams using software to detect documentation discrepancies, facilities rely on automated alerts to surface risks that would otherwise go unnoticed as staffing resource levels drop. Data-flagged cases are 3x more likely to result in confirmed diversion than routine reviews.

  • 49% of hospital pharmacy staff are currently using AI to support their work.
  • 25% of surveyed pharmacy professionals are using AI to detect drug diversion.
  • Teams using Prism Assistant run reports 96% faster and complete pre-investigation triage 90% faster.

Documentation compliance drives variance rates down to an all-time low.

Each variance represents a documentation discrepancy between what was dispensed, administered, wasted, or returned, creating operational friction and potentially hiding true diversion risks. Thanks to improved closed-loop auditing and machine learning algorithms, overall transaction variance rates have dropped by half from 12% to 6%. Today, 69% of hospital diversion teams resolve discrepancies in fewer than 10 hours per week, allowing compliance leaders to focus on high-risk documentation trends.

  • The rate of variances in controlled substance transactions has dropped from 12% in 2018, to 6% in 2025.
  • Hospitals using ControlCheck have confirmed 1,949 cases of drug diversion since September 2018.
  • Confirmed daily cases decreased in 2025 — indicating diversion may be growing less common or harder to carry out undetected.

Investigation volume levels off as programs reach maturity.

Quarterly investigations per hospital have held steady in the mid-40s (averaging 45.5 cases in Q4 2025) after climbing through 2023–2024. This plateau reflects program maturity with facilities establishing a consistent investigative rhythm, resolving cases faster, and driving overall compliance across care settings.

  • Average investigation length has dropped by over 40 days since 2023, holding steady at 49 days.
  • ControlCheck-enabled hospitals have confirmed 1,949 cases of diversion since 2018.
  • Patient-reported (39%) and colleague-reported (18%) cases yield the highest confirmation rates.

Access Past Diversion Trend Reports

Browse previous reports to see historical trends and shifts.

Diversion Trends 2025

An analysis of drug diversion investigations and events from 2024.

Diversion Trends 2024

An analysis of drug diversion investigations and events from 2022 through 2023

Diversion Trends 2022

An analysis of drug diversion investigations and events from 2020 through 2021